Skip to content
Open·Ingested 52 days ago, not re-verified since. Deadlines can change; confirm on the official page.

NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT PHASE I AWARD PROGRAM

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

View the solicitation

Free. Verify your email, then we send one reminder only.

Posted
Jul 27, 2026
Closes
Sep 21, 2026 (in 4 days)

See more open contract opportunities like this

Get alerted when new contract opportunities like this open.

Checking your account…

Free. Everyone sees new listings after 10 days. Unsubscribe anytime.

At a glance

This is a government contract opportunity posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF in the research and development in the physical category. The deadline is September 21, 2026, 5 days from now. This solicitation carries a Small Business Set Aside - Total set-aside.

Classification and identifiers

Industry (NAICS)
Research and Development in the Physical, Engineering, and Life Sciences (54171)
Product or service (PSC)
Health R&D Services; Health Care Services; Applied Research (AN12)
Solicitation number
75N98026R00109
Contracting office
NIH NCI
Set-aside
Small Business Set Aside - Total

Who can apply

Small businessLocation not specified

Small businesses can apply here. Check the eligibility details below to see if your organization fits.

Small Business Set Aside - Total

About this opportunity

The National Cancer Institute (NCI) invites small business concerns to submit research proposals under this Phase I Small Business Innovation Research (SBIR) contract solicitation. Firms with the capability to conduct research and development (R&D) in the health-related topic areas referred to below and described more fully in Section 11.0, and to commercialize the results of that R&D, are encouraged to participate. The topic areas that are being sought under this solicitation are: Topic 1: Development of therapeutic or preventative technologies for treatment or prevention of Pediatric Cancers and/or Rare Cancers. For this solicitation rare cancers with a 5-year survival rate of less than 50% are encouraged. Topic 2: Development of devices, diagnostic technologies, or digital health tools ...

Refine this search